183 related articles for article (PubMed ID: 24391441)
1. Novel delivery system for T-oligo using a nanocomplex formed with an alpha helical peptide for melanoma therapy.
Uppada SB; Erickson T; Wojdyla L; Moravec DN; Song Z; Cheng J; Puri N
Int J Nanomedicine; 2014; 9():43-53. PubMed ID: 24391441
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma.
Pitman RT; Wojdyla L; Puri N
Oncotarget; 2013 May; 4(5):761-71. PubMed ID: 23800953
[TBL] [Abstract][Full Text] [Related]
3. hnRNP C1/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhang.
Mulnix RE; Pitman RT; Retzer A; Bertram C; Arasi K; Crees Z; Girard J; Uppada SB; Stone AL; Puri N
Onco Targets Ther; 2013; 7():23-32. PubMed ID: 24379680
[TBL] [Abstract][Full Text] [Related]
4. Telomere-based DNA damage responses: a new approach to melanoma.
Puri N; Eller MS; Byers HR; Dykstra S; Kubera J; Gilchrest BA
FASEB J; 2004 Sep; 18(12):1373-81. PubMed ID: 15333580
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of Action of G-Quadruplex-Forming Oligonucleotide Homologous to the Telomere Overhang in Melanoma.
Chhabra G; Wojdyla L; Frakes M; Schrank Z; Leviskas B; Ivancich M; Vinay P; Ganapathy R; Ramirez BE; Puri N
J Invest Dermatol; 2018 Apr; 138(4):903-910. PubMed ID: 29203363
[TBL] [Abstract][Full Text] [Related]
6. Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.
Puri N; Pitman RT; Mulnix RE; Erickson T; Iness AN; Vitali C; Zhao Y; Salgia R
Cancer Lett; 2014 Feb; 343(1):14-23. PubMed ID: 24041868
[TBL] [Abstract][Full Text] [Related]
7. T-oligo as an anticancer agent in colorectal cancer.
Wojdyla L; Stone AL; Sethakorn N; Uppada SB; Devito JT; Bissonnette M; Puri N
Biochem Biophys Res Commun; 2014 Apr; 446(2):596-601. PubMed ID: 24632202
[TBL] [Abstract][Full Text] [Related]
8. Systemic siRNA delivery to tumors by cell-penetrating α-helical polypeptide-based metastable nanoparticles.
Liu Y; Song Z; Zheng N; Nagasaka K; Yin L; Cheng J
Nanoscale; 2018 Aug; 10(32):15339-15349. PubMed ID: 30070662
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma.
Zhao Y; Huo M; Xu Z; Wang Y; Huang L
Biomaterials; 2015 Nov; 68():54-66. PubMed ID: 26264646
[TBL] [Abstract][Full Text] [Related]
10. Hybrid melittin cytolytic Peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo.
Huang C; Jin H; Qian Y; Qi S; Luo H; Luo Q; Zhang Z
ACS Nano; 2013 Jul; 7(7):5791-800. PubMed ID: 23790040
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of melanoma angiogenesis by telomere homolog oligonucleotides.
Coleman C; Levine D; Kishore R; Qin G; Thorne T; Lambers E; Sasi SP; Yaar M; Gilchrest BA; Goukassian DA
J Oncol; 2010; 2010():928628. PubMed ID: 20652008
[TBL] [Abstract][Full Text] [Related]
12. Telomere-homologous G-rich oligonucleotides sensitize human ovarian cancer cells to TRAIL-induced growth inhibition and apoptosis.
Sarkar S; Faller DV
Nucleic Acid Ther; 2013 Jun; 23(3):167-74. PubMed ID: 23634944
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides.
Li GZ; Eller MS; Hanna K; Gilchrest BA
Exp Cell Res; 2004 Dec; 301(2):189-200. PubMed ID: 15530855
[TBL] [Abstract][Full Text] [Related]
14. Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage.
Lee MS; Yaar M; Eller MS; Rünger TM; Gao Y; Gilchrest BA
J Dermatol Sci; 2009 Dec; 56(3):154-62. PubMed ID: 19906512
[TBL] [Abstract][Full Text] [Related]
15. Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy.
Tan S; Sasada T; Bershteyn A; Yang K; Ioji T; Zhang Z
Nanomedicine (Lond); 2014 Apr; 9(5):635-47. PubMed ID: 23905577
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatment.
Weng D; Cunin MC; Song B; Price BD; Eller MS; Gilchrest BA; Calderwood SK; Gong J
Breast Cancer Res; 2010; 12(5):R71. PubMed ID: 20846433
[TBL] [Abstract][Full Text] [Related]
17. T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells.
Sarkar S; Faller DV
Oligonucleotides; 2011 Feb; 21(1):47-53. PubMed ID: 21281128
[TBL] [Abstract][Full Text] [Related]
18. Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential.
Longe HO; Romesser PB; Rankin AM; Faller DV; Eller MS; Gilchrest BA; Denis GV
Int J Cancer; 2009 Jan; 124(2):473-82. PubMed ID: 19003960
[TBL] [Abstract][Full Text] [Related]
19. Targeted nanoparticle-mediated LHPP for melanoma treatment.
Zhang Q; Xiong M; Liu J; Wang S; Du T; Kang T; Liu Y; Cheng H; Huang M; Gou M
Int J Nanomedicine; 2019; 14():3455-3468. PubMed ID: 31190803
[No Abstract] [Full Text] [Related]
20. Study of efficiency of the modular nanotransporter for targeted delivery of photosensitizers to melanoma cell nuclei in vivo.
Slastnikova TA; Rosenkranz AA; Lupanova TN; Gulak PV; Gnuchev NV; Sobolev AS
Dokl Biochem Biophys; 2012; 446():235-7. PubMed ID: 23132717
[No Abstract] [Full Text] [Related]
[Next] [New Search]
